{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 1997, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 1, "slideType": "executive_summary", "function": "summarize", "notes": "This is a classic short-seller research note cover page.", "imagePath": "https://imgproxy.kitesheet.com/Bij2o7BI6why3vR8oG8EK3pQlRPEa_usKmZJz1_zh6g/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80ZGVhOTcwN2FmNTgvcDAwMS5wbmc", "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/1", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "49b35616-8bdd-4f05-b34e-76b4fa89dc74", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "The Monster", "beatSlug": "overcoming-monster-the-monster", "evidence": "The problem for AtriCure and Convergent is presented", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/Gk-d0M5pLTm7j-bEauLLcDItv_DhuM3mmbwJzeJ078U/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80ZGVhOTcwN2FmNTgvcDAwMS5qcGc", "thumbSrc": "https://imgproxy.kitesheet.com/tLNqpDalECB5NYkr03BK9VDChpC4MGoM-7UeIIf86B0/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80ZGVhOTcwN2FmNTgvcDAwMS5wbmc", "thumbSrcAlt": "https://imgproxy.kitesheet.com/VnnQUcNodYCpG1-kup1gCyJMB8jmumRSYZI5XV1rpxk/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80ZGVhOTcwN2FmNTgvcDAwMS5qcGc" }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 2, "slideType": "table_of_contents", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/2", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "49b35616-8bdd-4f05-b34e-76b4fa89dc74", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "The Monster", "beatSlug": "overcoming-monster-the-monster", "evidence": "The problem for AtriCure and Convergent is presented", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 3, "slideType": "executive_summary", "function": "frame_problem", "notes": "The slide uses a strong thesis-driven opening statement typical of short-seller research reports.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/3", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "49b35616-8bdd-4f05-b34e-76b4fa89dc74", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "The Monster", "beatSlug": "overcoming-monster-the-monster", "evidence": "The problem for AtriCure and Convergent is presented", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 4, "slideType": "villain_critique", "function": "name_villain", "notes": "The slide uses a narrative structure to discredit the CONVERGE IDE trial results by highlighting procedural flaws and superior alternatives.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/4", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "49b35616-8bdd-4f05-b34e-76b4fa89dc74", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "The Monster", "beatSlug": "overcoming-monster-the-monster", "evidence": "The problem for AtriCure and Convergent is presented", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 5, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "Short-seller research note page.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/5", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-5", "loopMatches": [ { "to": 20, "from": 5, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "ddc2fc5b-a109-4c3d-a59c-6071803a7a20", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 0, "objective": "To identify patterns in AtriCure's business model and market prospects that indicate a flawed strategy", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.7, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "49b35616-8bdd-4f05-b34e-76b4fa89dc74", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "The Monster", "beatSlug": "overcoming-monster-the-monster", "evidence": "The problem for AtriCure and Convergent is presented", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 6, "slideType": "villain_critique", "function": "name_villain", "notes": "This is a short-seller research note criticizing AtriCure's growth prospects and market positioning.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/6", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-6", "loopMatches": [ { "to": 20, "from": 5, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "ddc2fc5b-a109-4c3d-a59c-6071803a7a20", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 0, "objective": "To identify patterns in AtriCure's business model and market prospects that indicate a flawed strategy", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.7, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 20, "from": 6, "beatId": "4e62a9ca-4c36-4797-a49e-21bad253e137", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "The Struggle", "beatSlug": "overcoming-monster-the-struggle", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 7, "slideType": "key_messages", "function": "summarize", "notes": "Research note discussing the technical advantages of PFA over RF/cryoablation and the diagnostic superiority of AcQMap over traditional mapping.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/7", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-7", "loopMatches": [ { "to": 20, "from": 5, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "ddc2fc5b-a109-4c3d-a59c-6071803a7a20", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 0, "objective": "To identify patterns in AtriCure's business model and market prospects that indicate a flawed strategy", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.7, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 20, "from": 6, "beatId": "4e62a9ca-4c36-4797-a49e-21bad253e137", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "The Struggle", "beatSlug": "overcoming-monster-the-struggle", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 8, "slideType": "villain_critique", "function": "name_villain", "notes": "The slide uses a short-seller thesis structure to argue that revenue growth has failed to translate into profitability or operating leverage.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/8", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-8", "loopMatches": [ { "to": 20, "from": 5, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "ddc2fc5b-a109-4c3d-a59c-6071803a7a20", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 0, "objective": "To identify patterns in AtriCure's business model and market prospects that indicate a flawed strategy", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.7, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 20, "from": 6, "beatId": "4e62a9ca-4c36-4797-a49e-21bad253e137", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "The Struggle", "beatSlug": "overcoming-monster-the-struggle", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 9, "slideType": "executive_summary", "function": "establish_context", "notes": "Includes capitalization table, financial results table, and medical background on AF.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/9", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-9", "loopMatches": [ { "to": 20, "from": 5, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "ddc2fc5b-a109-4c3d-a59c-6071803a7a20", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 0, "objective": "To identify patterns in AtriCure's business model and market prospects that indicate a flawed strategy", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.7, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 20, "from": 6, "beatId": "4e62a9ca-4c36-4797-a49e-21bad253e137", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "The Struggle", "beatSlug": "overcoming-monster-the-struggle", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 10, "slideType": "other", "function": "establish_context", "notes": "The slide explains the clinical rationale for AtriCure's products (ablation and AtriClip) by detailing the anatomy of the left atrial appendage and its role in stroke risk.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/10", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-10", "loopMatches": [ { "to": 20, "from": 5, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "ddc2fc5b-a109-4c3d-a59c-6071803a7a20", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 0, "objective": "To identify patterns in AtriCure's business model and market prospects that indicate a flawed strategy", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.7, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 20, "from": 6, "beatId": "4e62a9ca-4c36-4797-a49e-21bad253e137", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "The Struggle", "beatSlug": "overcoming-monster-the-struggle", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 11, "slideType": "problem_statement", "function": "diagnose_problem", "notes": "Includes footnotes referencing medical literature on atrial fibrillation treatments.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/11", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-11", "loopMatches": [ { "to": 20, "from": 5, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "ddc2fc5b-a109-4c3d-a59c-6071803a7a20", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 0, "objective": "To identify patterns in AtriCure's business model and market prospects that indicate a flawed strategy", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.7, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 20, "from": 6, "beatId": "4e62a9ca-4c36-4797-a49e-21bad253e137", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "The Struggle", "beatSlug": "overcoming-monster-the-struggle", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 12, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses anatomical diagrams to illustrate the difference in ablation coverage between the two study arms.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/12", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-12", "loopMatches": [ { "to": 20, "from": 5, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "ddc2fc5b-a109-4c3d-a59c-6071803a7a20", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 0, "objective": "To identify patterns in AtriCure's business model and market prospects that indicate a flawed strategy", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.7, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 20, "from": 6, "beatId": "4e62a9ca-4c36-4797-a49e-21bad253e137", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "The Struggle", "beatSlug": "overcoming-monster-the-struggle", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 13, "slideType": "villain_critique", "function": "name_villain", "notes": "This is a research note from Kerrisdale Capital criticizing AtriCure's strategic pivot to hybrid procedures.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/13", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-13", "loopMatches": [ { "to": 20, "from": 5, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "ddc2fc5b-a109-4c3d-a59c-6071803a7a20", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 0, "objective": "To identify patterns in AtriCure's business model and market prospects that indicate a flawed strategy", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.7, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 20, "from": 6, "beatId": "4e62a9ca-4c36-4797-a49e-21bad253e137", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "The Struggle", "beatSlug": "overcoming-monster-the-struggle", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 14, "slideType": "research-note", "function": "diagnose_problem", "notes": "The slide uses a narrative structure to expose the failure of clinical trials and the resulting strategic shift.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/14", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-14", "loopMatches": [ { "to": 20, "from": 5, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "ddc2fc5b-a109-4c3d-a59c-6071803a7a20", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 0, "objective": "To identify patterns in AtriCure's business model and market prospects that indicate a flawed strategy", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.7, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 20, "from": 6, "beatId": "4e62a9ca-4c36-4797-a49e-21bad253e137", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "The Struggle", "beatSlug": "overcoming-monster-the-struggle", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 15, "slideType": "preempt_rebuttal", "function": "preempt_rebuttal", "notes": "Critique of AtriCure's CONVERGE trial, specifically challenging the control group comparability.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/15", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-15", "loopMatches": [ { "to": 20, "from": 5, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "ddc2fc5b-a109-4c3d-a59c-6071803a7a20", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 0, "objective": "To identify patterns in AtriCure's business model and market prospects that indicate a flawed strategy", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.7, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 20, "from": 6, "beatId": "4e62a9ca-4c36-4797-a49e-21bad253e137", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "The Struggle", "beatSlug": "overcoming-monster-the-struggle", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 16, "slideType": "preempt_rebuttal", "function": "preempt_rebuttal", "notes": "The slide uses clinical study data to challenge the validity of the Convergent trial's control group by showing superior outcomes for modern catheter-based PW ablation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/16", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-16", "loopMatches": [ { "to": 20, "from": 5, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "ddc2fc5b-a109-4c3d-a59c-6071803a7a20", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 0, "objective": "To identify patterns in AtriCure's business model and market prospects that indicate a flawed strategy", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.7, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 20, "from": 6, "beatId": "4e62a9ca-4c36-4797-a49e-21bad253e137", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "The Struggle", "beatSlug": "overcoming-monster-the-struggle", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 17, "slideType": "other", "function": "illustrate_case", "notes": "This is a standard text-heavy research report page with bulleted data points and footnotes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/17", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-17", "loopMatches": [ { "to": 20, "from": 5, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "ddc2fc5b-a109-4c3d-a59c-6071803a7a20", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 0, "objective": "To identify patterns in AtriCure's business model and market prospects that indicate a flawed strategy", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.7, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 20, "from": 6, "beatId": "4e62a9ca-4c36-4797-a49e-21bad253e137", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "The Struggle", "beatSlug": "overcoming-monster-the-struggle", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 18, "slideType": "villain_critique", "function": "name_villain", "notes": "The slide functions as a 'short-thesis' critique, specifically targeting the viability of the Convergent procedure by highlighting the misalignment of incentives between AtriCure and the EPs who control patient referrals.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/18", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-18", "loopMatches": [ { "to": 20, "from": 5, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "ddc2fc5b-a109-4c3d-a59c-6071803a7a20", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 0, "objective": "To identify patterns in AtriCure's business model and market prospects that indicate a flawed strategy", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.7, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 20, "from": 6, "beatId": "4e62a9ca-4c36-4797-a49e-21bad253e137", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "The Struggle", "beatSlug": "overcoming-monster-the-struggle", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 19, "slideType": "villain_critique", "function": "name_villain", "notes": "Includes a direct quote from AtriCure CEO Michael Carrel (May 2020) which is then countered by the author's analysis.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/19", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-19", "loopMatches": [ { "to": 20, "from": 5, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "ddc2fc5b-a109-4c3d-a59c-6071803a7a20", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 0, "objective": "To identify patterns in AtriCure's business model and market prospects that indicate a flawed strategy", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.7, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 20, "from": 6, "beatId": "4e62a9ca-4c36-4797-a49e-21bad253e137", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "The Struggle", "beatSlug": "overcoming-monster-the-struggle", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 20, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "The slide uses a quote from a 2010 conference to contrast with 2020 data, arguing that the company's narrative is disingenuous.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/20", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-20", "loopMatches": [ { "to": 20, "from": 5, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "ddc2fc5b-a109-4c3d-a59c-6071803a7a20", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 0, "objective": "To identify patterns in AtriCure's business model and market prospects that indicate a flawed strategy", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.7, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 20, "from": 6, "beatId": "4e62a9ca-4c36-4797-a49e-21bad253e137", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "The Struggle", "beatSlug": "overcoming-monster-the-struggle", "evidence": "The document presents various critiques of AtriCure's business model and market prospects", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 21, "slideType": "research-note", "function": "expose_contradiction", "notes": "The slide uses academic citations to systematically dismantle the company's growth narrative.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/21", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 22, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "The slide uses a bulleted list to systematically dismantle the credibility of a research study.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/22", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 23, "slideType": "villain_critique", "function": "name_villain", "notes": "The slide uses a short-seller research note style to discredit the company's growth narrative and highlight the lack of operating leverage.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/23", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 24, "slideType": "appendix_data", "function": "analyze_data", "notes": "The text argues that the business is structurally unprofitable due to high R&D and SG&A costs that do not scale with revenue growth.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/24", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-24", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 25, "slideType": "villain_critique", "function": "expose_contradiction", "notes": "Includes specific footnotes (21, 22) challenging the company's interpretation of the STAR AF II trial results.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/25", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-25", "loopMatches": [ { "to": 31, "from": 25, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "3723b781-712f-4a89-8ac6-a6365db45803", "evidence": "The document presents a clear warning to investors about the risks of not acting", "position": 1, "objective": "To highlight the cost of inaction for investors who fail to recognize the threat of emerging technologies to AtriCure's business", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 26, "slideType": "appendix_methodology", "function": "establish_context", "notes": "This slide provides background context on medical device innovation in cardiac ablation, citing specific clinical trials and studies.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/26", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-26", "loopMatches": [ { "to": 31, "from": 25, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "3723b781-712f-4a89-8ac6-a6365db45803", "evidence": "The document presents a clear warning to investors about the risks of not acting", "position": 1, "objective": "To highlight the cost of inaction for investors who fail to recognize the threat of emerging technologies to AtriCure's business", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 27, "slideType": "thesis_headline", "function": "frame_problem", "notes": "The slide provides a detailed technical rationale for why PFA is superior to RF or cryo-ablation, focusing on the mechanism of electroporation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/27", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-27", "loopMatches": [ { "to": 31, "from": 25, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "3723b781-712f-4a89-8ac6-a6365db45803", "evidence": "The document presents a clear warning to investors about the risks of not acting", "position": 1, "objective": "To highlight the cost of inaction for investors who fail to recognize the threat of emerging technologies to AtriCure's business", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 31, "from": 27, "beatId": "b2363734-56f3-46ff-abfb-d7590b7e6299", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "The Victory", "beatSlug": "overcoming-monster-the-victory", "evidence": "The conclusion presents a clear victory for the thesis that AtriCure's growth is set to short-circuit", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 28, "slideType": "research-note", "function": "analyze_data", "notes": "The slide discusses the clinical performance of Farapulse's PFA catheter and its potential impact on the cardiac ablation market and competitors like AtriCure.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/28", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-28", "loopMatches": [ { "to": 31, "from": 25, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "3723b781-712f-4a89-8ac6-a6365db45803", "evidence": "The document presents a clear warning to investors about the risks of not acting", "position": 1, "objective": "To highlight the cost of inaction for investors who fail to recognize the threat of emerging technologies to AtriCure's business", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 31, "from": 27, "beatId": "b2363734-56f3-46ff-abfb-d7590b7e6299", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "The Victory", "beatSlug": "overcoming-monster-the-victory", "evidence": "The conclusion presents a clear victory for the thesis that AtriCure's growth is set to short-circuit", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 29, "slideType": "research-note", "function": "expose_contradiction", "notes": "The slide uses a narrative structure to contrast clinical trial data with AtriCure's market claims.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/29", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-29", "loopMatches": [ { "to": 31, "from": 25, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "3723b781-712f-4a89-8ac6-a6365db45803", "evidence": "The document presents a clear warning to investors about the risks of not acting", "position": 1, "objective": "To highlight the cost of inaction for investors who fail to recognize the threat of emerging technologies to AtriCure's business", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 31, "from": 27, "beatId": "b2363734-56f3-46ff-abfb-d7590b7e6299", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "The Victory", "beatSlug": "overcoming-monster-the-victory", "evidence": "The conclusion presents a clear victory for the thesis that AtriCure's growth is set to short-circuit", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 30, "slideType": "research-note", "function": "analyze_data", "notes": "The slide discusses the technical advantages of non-contact charge-density mapping over traditional PVI ablation and cites clinical trial results.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/30", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-30", "loopMatches": [ { "to": 31, "from": 25, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "3723b781-712f-4a89-8ac6-a6365db45803", "evidence": "The document presents a clear warning to investors about the risks of not acting", "position": 1, "objective": "To highlight the cost of inaction for investors who fail to recognize the threat of emerging technologies to AtriCure's business", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 31, "from": 27, "beatId": "b2363734-56f3-46ff-abfb-d7590b7e6299", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "The Victory", "beatSlug": "overcoming-monster-the-victory", "evidence": "The conclusion presents a clear victory for the thesis that AtriCure's growth is set to short-circuit", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 31, "slideType": "closing_ask", "function": "summarize", "notes": "This is a text-heavy research note conclusion page.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/31", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-31", "loopMatches": [ { "to": 31, "from": 25, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "3723b781-712f-4a89-8ac6-a6365db45803", "evidence": "The document presents a clear warning to investors about the risks of not acting", "position": 1, "objective": "To highlight the cost of inaction for investors who fail to recognize the threat of emerging technologies to AtriCure's business", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 31, "from": 27, "beatId": "b2363734-56f3-46ff-abfb-d7590b7e6299", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "The Victory", "beatSlug": "overcoming-monster-the-victory", "evidence": "The conclusion presents a clear victory for the thesis that AtriCure's growth is set to short-circuit", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 32, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "The slide uses a narrative-heavy format to dismantle the company's growth thesis.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/32", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-32", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 33, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/33", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-33", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-08d95731b035", "docSlug": "4dea9707af58", "documentTitle": "AtriCure, Inc. (ATRC)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2020-09-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 34, "slideType": "appendix_disclosure", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/34", "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-34", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-0c85e40ec39b", "docSlug": "9b248b07037e", "documentTitle": "CareDx, Inc. (CDNA)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2019-07-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 1, "slideType": "executive_summary", "function": "diagnose_problem", "notes": "This is a classic activist short-seller research note cover page.", "imagePath": "https://imgproxy.kitesheet.com/KScwSuJmXVpigTPGocffAVk4YpgKs2ckmcetH9nqyAo/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85YjI0OGIwNzAzN2UvcDAwMS5wbmc", "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-0c85e40ec39b/1", "deckHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/zEqOgZL5o5f243073YlVJ5DsGDFNJ1jLVsVjH4OPFKU/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85YjI0OGIwNzAzN2UvcDAwMS5qcGc", "thumbSrc": "https://imgproxy.kitesheet.com/AHbd27mRDAiQG-JYGHivla8xCwq3hyJYcp5Z5cpBsfI/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85YjI0OGIwNzAzN2UvcDAwMS5wbmc", "thumbSrcAlt": "https://imgproxy.kitesheet.com/d5N8t9FZbKtoqdpdiB4koNTCGuyZMkoT_W1UQStTuiw/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85YjI0OGIwNzAzN2UvcDAwMS5qcGc" }, { "docId": "019dd923-622c-750b-8b98-0c85e40ec39b", "docSlug": "9b248b07037e", "documentTitle": "CareDx, Inc. (CDNA)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2019-07-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 2, "slideType": "table_of_contents", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-0c85e40ec39b/2", "deckHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-0c85e40ec39b", "docSlug": "9b248b07037e", "documentTitle": "CareDx, Inc. (CDNA)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2019-07-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 3, "slideType": "executive_summary", "function": "diagnose_problem", "notes": "This is a short-seller research note from Kerrisdale Capital.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-0c85e40ec39b/3", "deckHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-0c85e40ec39b", "docSlug": "9b248b07037e", "documentTitle": "CareDx, Inc. (CDNA)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2019-07-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 4, "slideType": "research-note", "function": "diagnose_problem", "notes": "The slide argues that AlloSure has high false negative rates for subclinical rejection and that its commercial success is driven by regulatory loopholes rather than clinical utility.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-0c85e40ec39b/4", "deckHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b#slide-4", "loopMatches": [ { "to": 26, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "6ece1bb9-6dc2-4b36-a983-1e6b3a2a754d", "evidence": "The document emphasizes the risks of not acting on AlloSure's ineffectiveness", "position": 0, "objective": "Highlight the cost of inaction for investors", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-0c85e40ec39b", "docSlug": "9b248b07037e", "documentTitle": "CareDx, Inc. (CDNA)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2019-07-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 5, "slideType": "other", "function": "analyze_data", "notes": "This is a page from a research report rather than a standard presentation slide, containing dense narrative text and footnotes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-0c85e40ec39b/5", "deckHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b#slide-5", "loopMatches": [ { "to": 26, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "6ece1bb9-6dc2-4b36-a983-1e6b3a2a754d", "evidence": "The document emphasizes the risks of not acting on AlloSure's ineffectiveness", "position": 0, "objective": "Highlight the cost of inaction for investors", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-0c85e40ec39b", "docSlug": "9b248b07037e", "documentTitle": "CareDx, Inc. (CDNA)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2019-07-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 6, "slideType": "appendix_data", "function": "expose_gap", "notes": "The slide uses the NKF guidelines to argue that AlloSure's market is smaller than claimed by CareDx.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-0c85e40ec39b/6", "deckHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b#slide-6", "loopMatches": [ { "to": 26, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "6ece1bb9-6dc2-4b36-a983-1e6b3a2a754d", "evidence": "The document emphasizes the risks of not acting on AlloSure's ineffectiveness", "position": 0, "objective": "Highlight the cost of inaction for investors", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-0c85e40ec39b", "docSlug": "9b248b07037e", "documentTitle": "CareDx, Inc. (CDNA)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2019-07-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 7, "slideType": "key_messages", "function": "summarize", "notes": "This is a text-heavy research note slide from Kerrisdale Capital.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-0c85e40ec39b/7", "deckHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b#slide-7", "loopMatches": [ { "to": 26, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "6ece1bb9-6dc2-4b36-a983-1e6b3a2a754d", "evidence": "The document emphasizes the risks of not acting on AlloSure's ineffectiveness", "position": 0, "objective": "Highlight the cost of inaction for investors", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-0c85e40ec39b", "docSlug": "9b248b07037e", "documentTitle": "CareDx, Inc. (CDNA)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2019-07-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 8, "slideType": "executive_summary", "function": "establish_context", "notes": "Includes a table summarizing capitalization and historical financial results (2016-TTM).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-0c85e40ec39b/8", "deckHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b#slide-8", "loopMatches": [ { "to": 26, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "6ece1bb9-6dc2-4b36-a983-1e6b3a2a754d", "evidence": "The document emphasizes the risks of not acting on AlloSure's ineffectiveness", "position": 0, "objective": "Highlight the cost of inaction for investors", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-0c85e40ec39b", "docSlug": "9b248b07037e", "documentTitle": "CareDx, Inc. (CDNA)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2019-07-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 9, "slideType": "problem_statement", "function": "diagnose_problem", "notes": "The slide highlights a diagnostic gap in transplant monitoring, setting up a potential need for a more sensitive/specific diagnostic test.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-0c85e40ec39b/9", "deckHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b#slide-9", "loopMatches": [ { "to": 26, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "6ece1bb9-6dc2-4b36-a983-1e6b3a2a754d", "evidence": "The document emphasizes the risks of not acting on AlloSure's ineffectiveness", "position": 0, "objective": "Highlight the cost of inaction for investors", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 10, "from": 9, "beatId": "560a7993-5aa9-4db0-bc40-0dafc8803d9f", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem Statement", "beatSlug": null, "evidence": "Slides 9-10 introduce the problem of T-Cell-Mediated Rejection (TCMR/CMR) and Cell-Free DNA", "position": 0, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-0c85e40ec39b", "docSlug": "9b248b07037e", "documentTitle": "CareDx, Inc. (CDNA)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2019-07-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 10, "slideType": "problem_statement", "function": "diagnose_problem", "notes": "The slide is a text-heavy research note from Kerrisdale Capital.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-0c85e40ec39b/10", "deckHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b#slide-10", "loopMatches": [ { "to": 26, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "6ece1bb9-6dc2-4b36-a983-1e6b3a2a754d", "evidence": "The document emphasizes the risks of not acting on AlloSure's ineffectiveness", "position": 0, "objective": "Highlight the cost of inaction for investors", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 10, "from": 9, "beatId": "560a7993-5aa9-4db0-bc40-0dafc8803d9f", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem Statement", "beatSlug": null, "evidence": "Slides 9-10 introduce the problem of T-Cell-Mediated Rejection (TCMR/CMR) and Cell-Free DNA", "position": 0, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-0c85e40ec39b", "docSlug": "9b248b07037e", "documentTitle": "CareDx, Inc. (CDNA)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2019-07-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 11, "slideType": "research-note", "function": "diagnose_problem", "notes": "The slide provides a critical narrative on the efficacy of dd-cfDNA testing, highlighting the gap between academic hope and clinical utility.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-0c85e40ec39b/11", "deckHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b#slide-11", "loopMatches": [ { "to": 26, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "6ece1bb9-6dc2-4b36-a983-1e6b3a2a754d", "evidence": "The document emphasizes the risks of not acting on AlloSure's ineffectiveness", "position": 0, "objective": "Highlight the cost of inaction for investors", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-0c85e40ec39b", "docSlug": "9b248b07037e", "documentTitle": "CareDx, Inc. (CDNA)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2019-07-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 12, "slideType": "villain_critique", "function": "expose_contradiction", "notes": "This is a research note from Kerrisdale Capital criticizing CareDx's AlloSure product, citing clinical literature and expert opinion.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-0c85e40ec39b/12", "deckHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b#slide-12", "loopMatches": [ { "to": 26, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "6ece1bb9-6dc2-4b36-a983-1e6b3a2a754d", "evidence": "The document emphasizes the risks of not acting on AlloSure's ineffectiveness", "position": 0, "objective": "Highlight the cost of inaction for investors", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 16, "from": 12, "beatId": "98a96039-52a0-4f39-824a-abc50d3c23dc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Villain Critique", "beatSlug": null, "evidence": "Slides 12-16 critique AlloSure's clinical data and utility", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-0c85e40ec39b", "docSlug": "9b248b07037e", "documentTitle": "CareDx, Inc. (CDNA)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2019-07-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 13, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "This is a research note from Kerrisdale Capital critiquing a medical diagnostic product.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-0c85e40ec39b/13", "deckHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b#slide-13", "loopMatches": [ { "to": 26, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "6ece1bb9-6dc2-4b36-a983-1e6b3a2a754d", "evidence": "The document emphasizes the risks of not acting on AlloSure's ineffectiveness", "position": 0, "objective": "Highlight the cost of inaction for investors", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 16, "from": 12, "beatId": "98a96039-52a0-4f39-824a-abc50d3c23dc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Villain Critique", "beatSlug": null, "evidence": "Slides 12-16 critique AlloSure's clinical data and utility", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 14, "from": 13, "beatId": "85715bb9-0467-4cac-b70b-dcb33d24e2ba", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Expose Contradiction", "beatSlug": null, "evidence": "Slides 13-14 expose contradictions in AlloSure's clinical data", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-0c85e40ec39b", "docSlug": "9b248b07037e", "documentTitle": "CareDx, Inc. (CDNA)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2019-07-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 14, "slideType": "villain_critique", "function": "expose_gap", "notes": "Kerrisdale Capital research note criticizing CareDx's AlloSure product efficacy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-0c85e40ec39b/14", "deckHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b#slide-14", "loopMatches": [ { "to": 26, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "6ece1bb9-6dc2-4b36-a983-1e6b3a2a754d", "evidence": "The document emphasizes the risks of not acting on AlloSure's ineffectiveness", "position": 0, "objective": "Highlight the cost of inaction for investors", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 16, "from": 12, "beatId": "98a96039-52a0-4f39-824a-abc50d3c23dc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Villain Critique", "beatSlug": null, "evidence": "Slides 12-16 critique AlloSure's clinical data and utility", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 14, "from": 13, "beatId": "85715bb9-0467-4cac-b70b-dcb33d24e2ba", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Expose Contradiction", "beatSlug": null, "evidence": "Slides 13-14 expose contradictions in AlloSure's clinical data", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-0c85e40ec39b", "docSlug": "9b248b07037e", "documentTitle": "CareDx, Inc. (CDNA)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2019-07-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 15, "slideType": "problem_statement", "function": "diagnose_problem", "notes": "The slide argues that AlloSure is ineffective for TCMR detection, rendering it useless as a screening tool compared to cheaper alternatives.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-0c85e40ec39b/15", "deckHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b#slide-15", "loopMatches": [ { "to": 26, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "6ece1bb9-6dc2-4b36-a983-1e6b3a2a754d", "evidence": "The document emphasizes the risks of not acting on AlloSure's ineffectiveness", "position": 0, "objective": "Highlight the cost of inaction for investors", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 16, "from": 12, "beatId": "98a96039-52a0-4f39-824a-abc50d3c23dc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Villain Critique", "beatSlug": null, "evidence": "Slides 12-16 critique AlloSure's clinical data and utility", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-0c85e40ec39b", "docSlug": "9b248b07037e", "documentTitle": "CareDx, Inc. (CDNA)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2019-07-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 16, "slideType": "villain_critique", "function": "expose_gap", "notes": "Critique of CareDx's AlloSure product, focusing on market size limitations and clinical study failures.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-0c85e40ec39b/16", "deckHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b#slide-16", "loopMatches": [ { "to": 26, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "6ece1bb9-6dc2-4b36-a983-1e6b3a2a754d", "evidence": "The document emphasizes the risks of not acting on AlloSure's ineffectiveness", "position": 0, "objective": "Highlight the cost of inaction for investors", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 16, "from": 12, "beatId": "98a96039-52a0-4f39-824a-abc50d3c23dc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Villain Critique", "beatSlug": null, "evidence": "Slides 12-16 critique AlloSure's clinical data and utility", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-0c85e40ec39b", "docSlug": "9b248b07037e", "documentTitle": "CareDx, Inc. (CDNA)", "authorId": "53_Kerrisdale_Capital", "authorName": "Kerrisdale Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2019-07-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 17, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "The slide uses a box plot to demonstrate the lack of statistical separation between 'No rejection' and 'CMR' groups.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-0c85e40ec39b/17", "deckHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-0c85e40ec39b#slide-17", "loopMatches": [ { "to": 26, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "6ece1bb9-6dc2-4b36-a983-1e6b3a2a754d", "evidence": "The document emphasizes the risks of not acting on AlloSure's ineffectiveness", "position": 0, "objective": "Highlight the cost of inaction for investors", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-0600c263c598", "docSlug": "915e98b3b4e2", "documentTitle": "Credit Acceptance Corporation (CACC)", "authorId": "52_Citron_Research", "authorName": "Citron Research", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2026-03-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 6, "slideType": "comparison_table", "function": "analyze_data", "notes": "Includes a comparison table of competitors at the top and a benchmark example (AutoZone) at the bottom.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-0600c263c598/6", "deckHref": "/decks/019dd923-622c-750b-8b98-0600c263c598", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-0600c263c598#slide-6", "loopMatches": [ { "to": 12, "from": 2, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "75d52b86-e4b1-4b6e-b2c0-10b71ff478a0", "evidence": "The document repeatedly emphasizes the limited window to invest before institutional consensus catches up.", "position": 0, "objective": "What is the cost of not investing in CACC now?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 14, "from": 1, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "d8eea9a9-4800-4db5-9b62-ca38d6060cbb", "evidence": "The document presents data and logical reasoning to support its thesis.", "position": 1, "objective": "Is CACC's transformation into a technology platform a viable investment thesis?", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.6, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 8, "from": 5, "beatId": "aa2f3480-6ba8-48e0-b51c-404962653181", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The comparison table and discussion of the market's incorrect pricing of CACC agitate the problem.", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-0600c263c598", "docSlug": "915e98b3b4e2", "documentTitle": "Credit Acceptance Corporation (CACC)", "authorId": "52_Citron_Research", "authorName": "Citron Research", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2026-03-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 7, "slideType": "nominee_bio", "function": "introduce_nominees", "notes": "Includes a comparison table at the top referencing NVR and O'Reilly Auto as benchmarks.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-0600c263c598/7", "deckHref": "/decks/019dd923-622c-750b-8b98-0600c263c598", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-0600c263c598#slide-7", "loopMatches": [ { "to": 12, "from": 2, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "75d52b86-e4b1-4b6e-b2c0-10b71ff478a0", "evidence": "The document repeatedly emphasizes the limited window to invest before institutional consensus catches up.", "position": 0, "objective": "What is the cost of not investing in CACC now?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 14, "from": 1, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "d8eea9a9-4800-4db5-9b62-ca38d6060cbb", "evidence": "The document presents data and logical reasoning to support its thesis.", "position": 1, "objective": "Is CACC's transformation into a technology platform a viable investment thesis?", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.6, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 8, "from": 5, "beatId": "aa2f3480-6ba8-48e0-b51c-404962653181", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The comparison table and discussion of the market's incorrect pricing of CACC agitate the problem.", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-0600c263c598", "docSlug": "915e98b3b4e2", "documentTitle": "Credit Acceptance Corporation (CACC)", "authorId": "52_Citron_Research", "authorName": "Citron Research", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2026-03-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 8, "slideType": "thesis_headline", "function": "preempt_rebuttal", "notes": "Uses the 'bond market vs equity bears' argument to preempt short-seller thesis.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-0600c263c598/8", "deckHref": "/decks/019dd923-622c-750b-8b98-0600c263c598", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-0600c263c598#slide-8", "loopMatches": [ { "to": 12, "from": 2, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "75d52b86-e4b1-4b6e-b2c0-10b71ff478a0", "evidence": "The document repeatedly emphasizes the limited window to invest before institutional consensus catches up.", "position": 0, "objective": "What is the cost of not investing in CACC now?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 14, "from": 1, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "d8eea9a9-4800-4db5-9b62-ca38d6060cbb", "evidence": "The document presents data and logical reasoning to support its thesis.", "position": 1, "objective": "Is CACC's transformation into a technology platform a viable investment thesis?", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.6, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 8, "from": 5, "beatId": "aa2f3480-6ba8-48e0-b51c-404962653181", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The comparison table and discussion of the market's incorrect pricing of CACC agitate the problem.", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-0600c263c598", "docSlug": "915e98b3b4e2", "documentTitle": "Credit Acceptance Corporation (CACC)", "authorId": "52_Citron_Research", "authorName": "Citron Research", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2026-03-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 9, "slideType": "preempt_rebuttal", "function": "preempt_rebuttal", "notes": "The slide uses a 'preempt_rebuttal' structure to address three distinct bear theses: recession sensitivity, AI obsolescence, and credit quality.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-0600c263c598/9", "deckHref": "/decks/019dd923-622c-750b-8b98-0600c263c598", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-0600c263c598#slide-9", "loopMatches": [ { "to": 12, "from": 2, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "75d52b86-e4b1-4b6e-b2c0-10b71ff478a0", "evidence": "The document repeatedly emphasizes the limited window to invest before institutional consensus catches up.", "position": 0, "objective": "What is the cost of not investing in CACC now?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 14, "from": 1, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "d8eea9a9-4800-4db5-9b62-ca38d6060cbb", "evidence": "The document presents data and logical reasoning to support its thesis.", "position": 1, "objective": "Is CACC's transformation into a technology platform a viable investment thesis?", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.6, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 12, "from": 9, "beatId": "74abfdc8-b2d2-4a52-9ad0-7c9bab6fff32", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The preempt rebuttal and closing ask present the solution, emphasizing the potential for significant upside.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-0600c263c598", "docSlug": "915e98b3b4e2", "documentTitle": "Credit Acceptance Corporation (CACC)", "authorId": "52_Citron_Research", "authorName": "Citron Research", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2026-03-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 10, "slideType": "valuation_table", "function": "show_valuation_bridge", "notes": "Includes a Gordon Growth Model justification and an EPS build-up table.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-0600c263c598/10", "deckHref": "/decks/019dd923-622c-750b-8b98-0600c263c598", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-0600c263c598#slide-10", "loopMatches": [ { "to": 12, "from": 2, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "75d52b86-e4b1-4b6e-b2c0-10b71ff478a0", "evidence": "The document repeatedly emphasizes the limited window to invest before institutional consensus catches up.", "position": 0, "objective": "What is the cost of not investing in CACC now?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 14, "from": 1, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "d8eea9a9-4800-4db5-9b62-ca38d6060cbb", "evidence": "The document presents data and logical reasoning to support its thesis.", "position": 1, "objective": "Is CACC's transformation into a technology platform a viable investment thesis?", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.6, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 12, "from": 9, "beatId": "74abfdc8-b2d2-4a52-9ad0-7c9bab6fff32", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The preempt rebuttal and closing ask present the solution, emphasizing the potential for significant upside.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-0600c263c598", "docSlug": "915e98b3b4e2", "documentTitle": "Credit Acceptance Corporation (CACC)", "authorId": "52_Citron_Research", "authorName": "Citron Research", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2026-03-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 11, "slideType": "preempt_rebuttal", "function": "preempt_rebuttal", "notes": "Includes a financial table at the top and a risk/response table in the middle.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-0600c263c598/11", "deckHref": "/decks/019dd923-622c-750b-8b98-0600c263c598", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-0600c263c598#slide-11", "loopMatches": [ { "to": 12, "from": 2, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "75d52b86-e4b1-4b6e-b2c0-10b71ff478a0", "evidence": "The document repeatedly emphasizes the limited window to invest before institutional consensus catches up.", "position": 0, "objective": "What is the cost of not investing in CACC now?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 14, "from": 1, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "d8eea9a9-4800-4db5-9b62-ca38d6060cbb", "evidence": "The document presents data and logical reasoning to support its thesis.", "position": 1, "objective": "Is CACC's transformation into a technology platform a viable investment thesis?", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.6, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 12, "from": 9, "beatId": "74abfdc8-b2d2-4a52-9ad0-7c9bab6fff32", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The preempt rebuttal and closing ask present the solution, emphasizing the potential for significant upside.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-0600c263c598", "docSlug": "915e98b3b4e2", "documentTitle": "Credit Acceptance Corporation (CACC)", "authorId": "52_Citron_Research", "authorName": "Citron Research", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2026-03-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 12, "slideType": "closing_ask", "function": "closing_ask", "notes": "Includes a valuation table with time horizons and catalysts.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-0600c263c598/12", "deckHref": "/decks/019dd923-622c-750b-8b98-0600c263c598", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-0600c263c598#slide-12", "loopMatches": [ { "to": 12, "from": 2, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "75d52b86-e4b1-4b6e-b2c0-10b71ff478a0", "evidence": "The document repeatedly emphasizes the limited window to invest before institutional consensus catches up.", "position": 0, "objective": "What is the cost of not investing in CACC now?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 14, "from": 1, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "d8eea9a9-4800-4db5-9b62-ca38d6060cbb", "evidence": "The document presents data and logical reasoning to support its thesis.", "position": 1, "objective": "Is CACC's transformation into a technology platform a viable investment thesis?", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.6, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 12, "from": 9, "beatId": "74abfdc8-b2d2-4a52-9ad0-7c9bab6fff32", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The preempt rebuttal and closing ask present the solution, emphasizing the potential for significant upside.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-0600c263c598", "docSlug": "915e98b3b4e2", "documentTitle": "Credit Acceptance Corporation (CACC)", "authorId": "52_Citron_Research", "authorName": "Citron Research", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2026-03-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 13, "slideType": "appendix_disclosure", "function": "other", "notes": "The table at the top provides specific price targets and rationales for 12 and 24-month horizons.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-0600c263c598/13", "deckHref": "/decks/019dd923-622c-750b-8b98-0600c263c598", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-0600c263c598#slide-13", "loopMatches": [ { "to": 14, "from": 1, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "d8eea9a9-4800-4db5-9b62-ca38d6060cbb", "evidence": "The document presents data and logical reasoning to support its thesis.", "position": 1, "objective": "Is CACC's transformation into a technology platform a viable investment thesis?", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.6, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b98-0600c263c598", "docSlug": "915e98b3b4e2", "documentTitle": "Credit Acceptance Corporation (CACC)", "authorId": "52_Citron_Research", "authorName": "Citron Research", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2026-03-01 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 14, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b98-0600c263c598/14", "deckHref": "/decks/019dd923-622c-750b-8b98-0600c263c598", "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-0600c263c598#slide-14", "loopMatches": [ { "to": 14, "from": 1, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "d8eea9a9-4800-4db5-9b62-ca38d6060cbb", "evidence": "The document presents data and logical reasoning to support its thesis.", "position": 1, "objective": "Is CACC's transformation into a technology platform a viable investment thesis?", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.6, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }